Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sensor study asks: how does constraint therapy rewire arm muscles in cerebral palsy?

NCT ID NCT03099993

Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Children with unilateral cerebral palsy often rely on their stronger arm, leaving the weaker arm underused. Constraint-induced therapy forces them to use the weaker arm for hours a day over several weeks, and clinical tests show it improves movement. This study uses wearable sensors to measure muscle activity and arm motion in 28 children aged 6 to 17 during the therapy. Researchers want to understand which muscle problems the therapy changes, so they can find ways to make it more effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
constraint-induced movement therapy, a program that pushes children to use their weaker arm
What this could lead to
If researchers learn which muscle problems the therapy changes, they could pair it with treatments that relax stiff muscles or build strength, making therapy work better for children with unilateral cerebral palsy.
What could go wrong
The study is small and observational, so it can only suggest how the therapy works, not prove it. Results may not apply to all children with cerebral palsy, and the sensors may miss some changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Mar 2017

Finished

Apr 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 17 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants (excluding healthy volunteers) must have hemiparesis. * Children must be between 6 and 17 years of age. The protocol requires a minimum concentration difficult to obtain for children under 6 years. * Participants must be enrolled in a health insurance plan. Exclusion Criteria: * Inability to understand or follow instructions during 1h30. * Physical incapacity to carry out the requested movements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Unilateral cerebral palsy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy spastic hemiplegic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Unilateral cerebral palsy

Contacts and locations

Locations

  • CHU de Nantes

    Nantes, 46208, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.